Internal Medicine, Rheumatology · New York, NY
NPI
1629140033
Since 2006
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
12 E 86th St Ofc 3
New York, NY, 10028
Phone (212) 517-9555
Groups this clinician bills Medicare through
Medicare paid, 2024
$35K
1,071 services
Medicare patients, 2024
104
Average age 73
Drug cost, 2024
$2.8M
825 prescriptions
Company payments, 2025
$453
From 6 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jay B Adlersberg was code 99214 (office e&m - established), 145 times for 80 patients. In total Jay B Adlersberg billed 1,071 services in 49 codes, and Medicare paid $35K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-07-02.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 145 | 80 | $105.45 | $15K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 65 | 14 | $51.66 | $3,358 |
| 36415 Venipuncture Blood Collection | Office | 47 | 40 | $8.65 | $407 |
| 82784 Immunoassay | Office | 42 | 14 | $9.11 | $383 |
| 85025 Blood Count | Office | 34 | 33 | $7.61 | $259 |
| 86146 Immunoassay | Office | 34 | 11 | $24.94 | $848 |
| 85651 Clinical Chemistry | Office | 34 | 33 | $4.18 | $142 |
| 86147 Immunoassay | Office | 32 | 11 | $24.94 | $798 |
| 80053 Clinical Chemistry | Office | 31 | 31 | $10.35 | $321 |
| 84550 Clinical Chemistry | Office | 30 | 30 | $4.36 | $131 |
| 86431 Immunoassay | Office | 23 | 23 | $5.32 | $122 |
| 99205 Office E&M - New | Office | 22 | 22 | $170.82 | $3,758 |
| 99215 Office E&M - Established | Office | 17 | 12 | $151.30 | $2,572 |
| 82550 Clinical Chemistry | Office | 15 | 15 | $5.95 | $89.32 |
| 83615 Clinical Chemistry | Office | 15 | 15 | $5.53 | $82.88 |
By year: 2022 $59K for 2,009 services; 2023 $48K for 1,670 services; 2024 $35K for 1,071 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 47 | 40 | $8.65 | $407 |
| 82784 Immunoassay | 42 | 14 | $9.11 | $383 |
| 85025 Blood Count | 34 | 33 | $7.61 | $259 |
| 86146 Immunoassay | 34 | 11 | $24.94 | $848 |
| 85651 Clinical Chemistry | 34 | 33 | $4.18 | $142 |
| 86147 Immunoassay | 32 | 11 | $24.94 | $798 |
| 80053 Clinical Chemistry | 31 | 31 | $10.35 | $321 |
| 84550 Clinical Chemistry | 30 | 30 | $4.36 | $131 |
| 86431 Immunoassay | 23 | 23 | $5.32 | $122 |
| 82550 Clinical Chemistry | 15 | 15 | $5.95 | $89.32 |
Medicare prescription drug claims, 2024
In 2024, the drug Jay B Adlersberg prescribed most often to Medicare patients was Prednisone, with 158 prescriptions and refills. In total Jay B Adlersberg wrote 825 Medicare prescriptions that cost $2.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prednisone Generic | 158 | 183 | 51 | $1,255 |
| Remicade Infliximab | 88 | 147 | 21 | $581K |
| Methotrexate Methotrexate Sodium | 58 | 132 | 15 | $1,449 |
| Hydroxychloroquine Sulfate Generic | 41 | 57 | 11 | $777 |
| Meloxicam Generic | 35 | 37 | Under 11 | $276 |
| Methylprednisolone Generic | 31 | 31 | 20 | $389 |
| Simponi Aria Golimumab | 25 | 37 | Under 11 | $189K |
| Mycophenolate Mofetil Generic | 22 | 28 | Under 11 | $1,979 |
| Orencia Abatacept/Maltose | 22 | 22 | Under 11 | $100K |
| Ridaura Auranofin | 20 | 20 | Under 11 | $24K |
| Inflectra Infliximab-Dyyb | 20 | 31 | Under 11 | $90K |
| Cosentyx Sensoready (2 Pens) Secukinumab | 17 | 22 | Under 11 | $188K |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 16 | 16 | Under 11 | $539 |
| Sulfasalazine Dr Sulfasalazine | 16 | 22 | Under 11 | $417 |
| Renflexis Infliximab-Abda | 13 | 23 | Under 11 | $42K |
Brand drugs: 346 claims; generic drugs: 479 claims; opioid claims: 21.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jay B Adlersberg $453 ($453 in general payments such as food, travel and fees) from 6 companies. The largest payer was Amgen Inc. with $316.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.